ATE322163T1 - Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind - Google Patents

Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind

Info

Publication number
ATE322163T1
ATE322163T1 AT97931014T AT97931014T ATE322163T1 AT E322163 T1 ATE322163 T1 AT E322163T1 AT 97931014 T AT97931014 T AT 97931014T AT 97931014 T AT97931014 T AT 97931014T AT E322163 T1 ATE322163 T1 AT E322163T1
Authority
AT
Austria
Prior art keywords
derivatives useful
neuramidase inhibitors
cyclopentan
substituted
inhibitors
Prior art date
Application number
AT97931014T
Other languages
English (en)
Inventor
Yarlagadda S Babu
Pooran Chand
John A Montgomery
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Application granted granted Critical
Publication of ATE322163T1 publication Critical patent/ATE322163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02—Saturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97931014T 1996-06-14 1997-06-13 Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind ATE322163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1993096P 1996-06-14 1996-06-14
US4401097P 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
ATE322163T1 true ATE322163T1 (de) 2006-04-15

Family

ID=26692776

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97931014T ATE322163T1 (de) 1996-06-14 1997-06-13 Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind

Country Status (20)

Country Link
US (1) US6410594B1 (de)
EP (1) EP0933993B1 (de)
JP (1) JP3481255B2 (de)
KR (1) KR20000016669A (de)
CN (1) CN1227466A (de)
AT (1) ATE322163T1 (de)
AU (1) AU723360B2 (de)
BR (1) BR9711095A (de)
CA (1) CA2258217C (de)
CZ (1) CZ412898A3 (de)
DE (1) DE69735634T2 (de)
DK (1) DK0933993T3 (de)
ES (1) ES2263179T3 (de)
NO (1) NO311885B1 (de)
NZ (1) NZ333437A (de)
PL (1) PL330407A1 (de)
PT (1) PT933993E (de)
RO (1) RO121027B1 (de)
SK (1) SK171698A3 (de)
WO (1) WO1997047194A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033781A1 (en) * 1997-12-17 1999-07-08 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
TR200003065T2 (tr) * 1998-04-23 2001-02-21 Abbott Laboratories Nöraminidazların inhibitörleri olarak pirolidinler.
US6518305B1 (en) * 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
CA2329660A1 (en) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
AU1520300A (en) * 1998-11-05 2000-05-29 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
AU5479700A (en) 1999-06-28 2001-01-31 Biocryst Pharmaceuticals, Inc. Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
AU2001243253A1 (en) * 2000-02-24 2001-09-03 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
JP4851185B2 (ja) 2003-05-16 2012-01-11 ジェレックスインターナショナル株式会社 アレルギー症状抑制剤及び空気濾過フィルター
BRPI0707769A2 (pt) * 2006-02-13 2011-05-10 Biocryst Pharm Inc tratamentos antivirais intravenosos
US20070203241A1 (en) * 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
WO2011150205A2 (en) * 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102603577A (zh) * 2011-01-19 2012-07-25 董慧珍 一种抗流感和禽流感药物的衍生物及其用途
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN104402754B (zh) * 2014-11-25 2016-03-02 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN104387288B (zh) * 2014-11-25 2016-04-20 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN104447390B (zh) * 2014-12-03 2016-03-02 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496839B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496857B (zh) * 2014-12-10 2016-10-12 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN110128288B (zh) * 2018-02-02 2023-07-28 浙江九洲药业股份有限公司 一种氨基取代的环戊烷甲酸烷基酯衍生物的制备方法
WO2023192165A1 (en) * 2022-03-27 2023-10-05 Tranexamic Technologies, Llc Tranexamic class arginine and histidine mimics as therapeutic agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT979736B (it) 1972-03-07 1974-09-30 Ethyl Corp Detersivo contenente un sequestran te e relativo metodo di impiego
US4426391A (en) 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
JPS59163365A (ja) 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
EP0130119B1 (de) 1983-06-23 1988-11-09 Merck & Co. Inc. (Acyloxyalkoxy)-carbonyl-Derivate als bioreversible Vorprodukte für Primär- und Sekundäramin-Funktionen in Arzneien, ihre Herstellung und pharmazeutische Produkte, die sie enthalten
US4873019A (en) 1986-12-20 1989-10-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclopentane derivatives
CA2075181C (en) 1990-02-02 1997-12-09 Theodros Asberom 4,5-bridged-2,3,4,5-tetrahydro-1h-3-benzazepine-7-ols
WO1992016541A1 (en) 1991-03-12 1992-10-01 Mect Corporation Synthesis of sialic acid and synthetic intermediate therefor
JP2951765B2 (ja) 1991-09-10 1999-09-20 三共株式会社 エナミノエステル類およびその製法
AU673824B2 (en) 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
CA2176414A1 (en) 1995-05-18 1996-11-19 S. David Kimball Acyl guanidine and amidine prodrugs
EP1023295A4 (de) 1997-02-06 2001-01-24 Merck & Co Inc Prodrogen von fibrinogenrezeptor-antagonisten
WO1999033781A1 (en) 1997-12-17 1999-07-08 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
CA2329660A1 (en) 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
TR200003065T2 (tr) 1998-04-23 2001-02-21 Abbott Laboratories Nöraminidazların inhibitörleri olarak pirolidinler.

Also Published As

Publication number Publication date
PL330407A1 (en) 1999-05-10
EP0933993B1 (de) 2006-04-05
KR20000016669A (ko) 2000-03-25
WO1997047194A1 (en) 1997-12-18
AU3475097A (en) 1998-01-07
NO985821L (no) 1999-02-10
SK171698A3 (en) 1999-10-08
BR9711095A (pt) 2001-07-17
JP3481255B2 (ja) 2003-12-22
EP0933993A1 (de) 1999-08-11
PT933993E (pt) 2006-10-31
CA2258217A1 (en) 1997-12-18
CA2258217C (en) 2005-08-09
JP2000505088A (ja) 2000-04-25
DK0933993T3 (da) 2006-08-14
NO311885B1 (no) 2002-02-11
CZ412898A3 (cs) 1999-08-11
NO985821D0 (no) 1998-12-11
US6410594B1 (en) 2002-06-25
DE69735634D1 (de) 2006-05-18
DE69735634T2 (de) 2007-05-03
NZ333437A (en) 2000-05-26
RO121027B1 (ro) 2006-11-30
AU723360B2 (en) 2000-08-24
EP0933993A4 (de) 2004-09-08
ES2263179T3 (es) 2006-12-01
CN1227466A (zh) 1999-09-01

Similar Documents

Publication Publication Date Title
ATE322163T1 (de) Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
BR0209777A (pt) Formulações lìquidas estáveis
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
EE200200217A (et) Asendatud indoolid NFkB aktiivsuse moduleerimiseks, nende valmistamismeetod ja kasutamine ning ravim ja selle valmistamismeetod
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
SE9602442D0 (sv) Administration of pharmaceuticals
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
NO324229B1 (no) 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
DK0506778T3 (da) Substituerede 4-phenyl-4-piperidincarboxamider med både lokal anæstetisk og analgetisk virkning samt fremgangsmåder til deres fremstilling
ES2058343T3 (es) Piridinas disubstituidas.
DK1242410T3 (da) Nye forbindelser
HUP0200152A2 (hu) KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
RS53223B (en) METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C
IT1269880B (it) Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono
EA200000168A1 (ru) Фармацевтическая композиция, снижающая продуцирование белка мср-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0933993

Country of ref document: EP